Bibliography

Found 55 results

Filters: Keyword is HIV [Clear All Filters]

2013

Cassol E, Misra V, Morgello S, Gabuzda D. Applications and Limitations of Inflammatory Biomarkers for Studies on Neurocognitive Impairment in HIV Infection. Journal of NeuroImmune Pharmacology [Internet]. 2013 ;8(5):1087-1097. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24259252

Pacifici M, Delbue S, Ferrante P, Jeansonne D, Kadri F, Nelson S, Velasco-Gonzalez C, Zabaleta J, Peruzzi F. Cerebrospinal Fluid miRNA Profile in HIV-Encephalitis. Journal of Cellular Physiology [Internet]. 2013 ;228(5):1070-1075. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23042033

Spitsin S, Stevens K, Douglas SD. Expression of substance P, Neurokinin-1 receptor and immune markers in the brains of individuals with HIV-1 associated neuropathology. Journal of the Neurological Sciences [Internet]. 2013 ;334(1-2):18-23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23916293

Orellanna JA, Saez JC, Bennett MV, Berman JW, Morgello S, Eugenin EA. HIV increases the release of dickkopf-1 protein from human astrocytes by a Cx43 hemichannel-dependent mechanism. Journal of Neurochemistry [Internet]. 2013 ;128(5):752-763. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24134157

Cassol E, Misra V, Holman AG, Kamat A, Morgello S, Gabuzda D. Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors. BMC Infectious Diseases [Internet]. 2013 ;13:203. Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=23641933

Megra B, Eugenin EA, Roberts TK, Morgello S, Berman JW. Protease resistant protein cellular isoform (PrP(c)) as a biomarker: clues into the pathogenesis of HAND. Journal of NeuroImmune Pharmacology [Internet]. 2013 ;8(5):1159-1166. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23616272

2012

Akay C, Lindl KA, Shyam N, Nabet B, Goenaga-Vazquez Y, Ruzbarsky J, Wang Y, Kolson DL, Jordan-Sciutto KL. Activation status of integrated stress response pathways in neurones and astrocytes of HIV-associated neurocognitive disorders (HAND) cortex. Neuropathology and Applied Neurobiology [Internet]. 2012 ;38(2):175-200. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21883374

Robinson-Papp JS, Elliott K, Pizzirusso M, Morgello S. Autonomic neuropathy in HIV: A case report and review of potential symptoms in an advanced-stage, HIV cohort. World Journal of AIDS [Internet]. 2012 ;2:265-269. Available from: http://www.scirp.org/journal/PaperInformation.aspx?paperID=22612

Blackstone K, Moore DJ, Franklin DR, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, et al. Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol. 2012 ;26(6):894-908.

Festa L, Meucci O. Effects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergism. Current HIV Research [Internet]. 2012 ;10(5):453-462. Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=22591369

Kamat A, Lyons JL, Misra V, Uno H, Morgello S, Singer EJ, Gabuzda D. Monocyte Activation Markers in Cerebrospinal Fluid Are Associated with Impaired Neurocognitive Testing in Advanced HIV Infection. In: AAN Meeting. AAN Meeting. New Orleans, Louisiana; 2012. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22569268

Arentoft A, Byrd D, Robbins RN, Monzones J, Miranda C, Rosario A, Coulehan K, Fuentes A, Kubo-Germano K, D'Aquila E, et al. Multidimensional effects of acculturation on English-language neuropsychological test performance among HIV+ Caribbean Latinas/os. Journal of Clinical and Experimental Neuropsychology [Internet]. 2012 ;34(8):814-825. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22624844

Zhou L, Pupo GM, Gupta P, Liu B, Tran SL, Rahme R, Wang B, Rua R, Rizos H, Carroll A, et al. A parallel genome-wide mRNA and microRNA profiling of the frontal cortex of HIV patients with and without HIV-associated dementia shows the role of axon guidance and downstream pathways in HIV-mediated neurodegeneration. BMC Genomics. 2012 ;13:677.

2011

Jernigan TL, Archibald SL, Fennema-Notestine C, Taylor MJ, Theilmann RJ, Julaton MD, Notestine RJ, Wolfson T, Letendre SL, Ellis RJ, et al. Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol. 2011 ;17(3):248-57.

Heaton RK, Franklin DR, Ellis RJ, J McCutchan A, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011 ;17(1):3-16.

2010

Suh H-S, Cosenza-Nashat MA, Choi N, Zhao ML, Li JF, Pollard JW, Jirtle RL, Goldstein H, Lee SC. Insulin-like growth factor 2 receptor is an IFNgamma-inducible microglial protein that facilitates intracellular HIV replication: implications for HIV-induced neurocognitive disorders. The American Journal of Pathology [Internet]. 2010 ;177:2446-2458. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20889566

2009

Levine AJ, Singer EJ, Sinsheimer JS, Hinkin CH, Papp J, Dandekar S, Giovanelli A, Shapshak P. CCL3 genotype and current depression increase risk of HIV-associated dementia. Neurobehavioral HIV Medicine [Internet]. 2009 ;1:1-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20725607

Khanlou N, Moore D, Chana G, Cherner M, Lazzaretto D, Dawes S, Grant I, Masliah E, Everall I. Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection. Journal of Neurovirology [Internet]. 2009 ;15:131-138. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19115126

Gongvatana A, Schweinsburg BC, Taylor MJ, Theilmann RJ, Letendre SL, Alhassoon OM, Jacobus J, Woods SP, Jernigan TL, Ellis RJ, et al. White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J Neurovirol. 2009 ;15(2):187-95.

2008

Eugenin EA, Morgello S, Klotman ME, Mosoian A, Lento PA, Berman JW, Schecter AD. Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease. The American Journal of Pathology [Internet]. 2008 ;172:1100-11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18310503

Robinson-Papp JS, Byrd D, Mindt MRivera, Oden NL, Simpson DM, Morgello S. Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort. Archives of Neurology [Internet]. 2008 ;65:1096-101. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18695060

2007

Rohit M, Levine AJ, Hinkin CH, Abramyan S, Saxton EH, Valdes-Sueiras M, Singer EJ. Education correction using years in school or reading grade-level equivalent? Comparing the accuracy of two methods in diagnosing HIV-associated neurocognitive impairment. Journal of the International Neuropsychological Society (JINS) [Internet]. 2007 ;13(3):462-470. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17445295

Ellis RJ, Langford D, Masliah E. HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nature Reviews. Neuroscience [Internet]. 2007 ;8:33-44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17180161

Huang D, Cossoy MB, Li M, Choi D, Taege A, Staugaitis SM, Rehm S, Ransohoff RM. Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus-negative patients. Annals of Neurology [Internet]. 2007 ;62:34-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17328067

Letendre S, Ances BM, Gibson S, Ellis RJ. Neurologic complications of HIV disease and their treatment. Topics in HIV Medicine: A Publication of the International AIDS Society, USA [Internet]. 2007 ;15:32-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17485785

Pages